Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Reexamination Certificate
2008-05-06
2008-05-06
Fetterolf, Brandon (Department: 1642)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
C435S004000, C435S007230
Reexamination Certificate
active
07368098
ABSTRACT:
The present invention relates to the use of a protein that is differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as a biomolecular target for tumor treatment therapies. The protein is also expressed in tissues from adenocarcinoma, non-melanoma, and renal carcinoma cells. Immunotherapeutic and immunoimaging agents that specifically bind to an identified brain tumor target protein are provided. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention.
REFERENCES:
patent: 1033404 (2000-09-01), None
patent: WO 00/20590 (2000-04-01), None
patent: WO 0020590 (2000-04-01), None
Mariani et al.; Glioma Cell Motility is Associated With Reduced Transcription of Proapoptotic and Proliferation Genes: A CDNA Microarray Analysis, J of Neuro-Oncology, (2001), 53: 161-176.
Markert et al. Differential Gene Expression Profiling in Human Brain Tumors, Physiol Genomics, (2001), 5: 21-33.
Kroes et al., The Identification of Novel Therapeutic Targets for the Treatment of Malignant Brain Tumors, Cancer Letters, (2000), 191-198.
Reis et al., Short Communication Genetic Profile of Gliosarcomas, American J of Pathology, (2000), 156: (2) 425-432.
Fredriksson et al., Novel Human G Protein-Coupled Receptors With Long N-Terminals Containing GPS Domains and SER/THR-Rich Regions, FEBS Letters, (2002), 531: 407-414.
Liu et al., GPR56, A Novel Secretin-Like Human G-Protein-Coupled Receptor Gene, Genomics, (1999), 55: 296-305.
Yano et al., Differential Expression of β-Catenin in Human Gliobastoma Multiforme and Normal Brain Tissue, Neurological Research, (2000), 22: 650-656.
Zendman et al., TM7XN1, A Novel Human EGF-TM7-Like CDNA, Detected With MRNA Differential Display Using Human Melonoma Cell Lines With Different Metastatic Potential, FEBS Letters, (1999), 292-298.
Chin Daniel J.
Foehr Erik
Gonzalez-Zulueta Mirella
Mueller Sabine
Fetterolf Brandon
Lahive & Cockfield LLP
Medarex Inc.
Remillard, Esq. Jane E.
LandOfFree
Use of biomolecular targets in the treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of biomolecular targets in the treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of biomolecular targets in the treatment and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2773857